Status:
UNKNOWN
Neuromuscular Electrical Stimulation in Patients With COVID19 Associated Pneumonia
Lead Sponsor:
University of Turin, Italy
Collaborating Sponsors:
San Luigi Gonzaga Hospital
Conditions:
COVID-19 Pneumonia
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Neuromuscular electrical stimulation (NMES) has been considered as a promising approach for the early rehabilitation of patients in and/or after the intensive care unit (ICU). Aim of this study is to ...
Detailed Description
This prospective, randomized, controlled, parallel-group, single-blind trial will include 80 patients who had undergone mechanical or non-invasive ventilation following pneumonia-induced respiratory f...
Eligibility Criteria
Inclusion
- age above 18 years
- respiratory (PaO2/FiO2 ratio \> 180 mmHg) and hemodynamic stability for at least two days after withdrawal of mechanical ventilation and neuromuscular blocking agents
Exclusion
- pregnancy
- known or suspected malignancy in the lower limbs
- body mass index equal or greater than 35 kg/m2
- conditions preventing NMES treatment (e.g., deep vein thrombosis, skin lesions, rhabdomyolysis)
- conditions preventing the outcome assessment (e.g., amputation or inability to transfer independently from bed to chair before hospital admission)
- presence of an implanted cardiac pacemaker or defibrillator
Key Trial Info
Start Date :
April 17 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2020
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04382729
Start Date
April 17 2020
End Date
July 1 2020
Last Update
May 11 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
San Luigi Gonzaga Hospital
Orbassano, TO, Italy, 10043